Chemoinformaics analysis of 2-Hexadecenoic acid, methyl ester, (E)-
| Molecular Weight | 268.441 | nRot | 13 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 2 |
| Exact Molecular Weight | 268.24 | nRing | 0 |
| Solubility: LogS | -6.395 | nHRing | 0 |
| Solubility: LogP | 6.776 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 51.3314 |
| nHD | 0 | BPOL | 34.7066 |
| QED | 0.253 |
| Synth | 2.154 |
| Natural Product Likeliness | 1.036 |
| NR-PPAR-gamma | 0.047 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.005 |
| HIA | 0.005 |
| CACO-2 | -4.629 |
| MDCK | 0.0000182 |
| BBB | 0.381 |
| PPB | 0.971688 |
| VDSS | 1.762 |
| FU | 0.0199061 |
| CYP1A2-inh | 0.89 |
| CYP1A2-sub | 0.192 |
| CYP2c19-inh | 0.586 |
| CYP2c19-sub | 0.072 |
| CYP2c9-inh | 0.427 |
| CYP2c9-sub | 0.937 |
| CYP2d6-inh | 0.052 |
| CYP2d6-sub | 0.109 |
| CYP3a4-inh | 0.52 |
| CYP3a4-sub | 0.07 |
| CL | 6.296 |
| T12 | 0.34 |
| hERG | 0.165 |
| Ames | 0.006 |
| ROA | 0.016 |
| SkinSen | 0.965 |
| Carcinogencity | 0.263 |
| EI | 0.979 |
| Respiratory | 0.692 |
| NR-Aromatase | 0.038 |
| Antiviral | Yes |
| Prediction | 0.642868 |